Sg Americas Securities, LLC Praxis Precision Medicines, Inc. Transaction History

Sg Americas Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$0.8 - $4.98 $2,773 - $17,265	3,467 Added 25.23%	17,206 $14,000
Q4 2022 Feb 02, 2023	SELL	$1.88 - $36.45 $7,666 - $148,643	-4,078 Reduced 22.89%	13,739 $33,000
Q3 2022 Oct 31, 2022	SELL	$2.5 - $37.95 $78,515 - $1.19 Million	-31,406 Reduced 63.8%	17,817 $40,000
Q2 2022 Jul 29, 2022	BUY	$1.75 - $11.34 $86,140 - $558,188	49,223 New	49,223 $121,000
Q1 2022 Apr 29, 2022	SELL	$10.21 - $20.29 $98,373 - $195,494	-9,635 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$16.76 - $22.99 $165,052 - $226,405	-9,848 Reduced 50.55%	9,635 $190,000
Q3 2021 Nov 01, 2021	BUY	$13.15 - $22.56 $256,201 - $439,536	19,483 New	19,483 $360,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.26B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.